- Research & Predictions
- Clear, jargon-free predictions for institutional investors
- Rapidly prepared research: : within 24 hours in some cases
- Scope of research scope is unlimited and tailored to Subscribers
- Second Opinion
- Succinct explanations of written opinions for corporate executives
- Alternative solutions to mandatory directives in written opinions
- Locate competent private counsel when executives need different lawyers
Selected Cases
AHP 4: Fen-phen reserves were consitently low
As AHP continually changed its litigation reserves for fen-phen, Verdict repeatedly predicted the reserves were inadequate. The final cost was $20 billion.
BP CEO Resigns over Propane
Because the complaint showed that BP's propane liability would be proven by its own records, Verdict warned that the class action was a serious threat to BP.
Grace reverse mergers failed to avoid asbestos liability
Reverse mergers with Grace cost Sealed Air $732 million & Fresenius $115 million in asbestos liabilities.
Maytag-Whirpool Merger
Hours before Justice announced its decision, Verdict predicted the merger would be approved because Bush's approval was required, and he was preoccupied with Iraq.
Prilosec: Andrx predicted to lose when stock was $55
After 12 days of a 42 day trial, a Verdict Subscriber sold Andrx stock for $55 per share: when judge ruled for Astra Zeneca, Andrx sold for $20 saving the Subscriber $175 million.
Valassis: Judge will deny Murdock’s new trial motion
With a $300 million Federal judgment, Murdoch faced a state trial in the same dispute. He settled for $500 million in 3 months.